Fact CheckerSign in

NCT07863310Recruiting

Effects of Nurse-Led Stigma-Reduction Education in Epilepsy

Effects of Nurse-Led Stigma-Reduction Education on Internalized Stigma, Illness Concealment, and Self-Management in Epilepsy: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

This randomized controlled trial aims to evaluate the effect of a nurse-led, stigma-reduction-based epilepsy education program on perceived/internalized stigma, concealment of epilepsy, and self-management among adults with epilepsy. Participants will be randomly assigned to an intervention group or a control group. The intervention group will receive a structured nurse-led education program consisting of four weekly sessions, each lasting approximately 45-60 minutes. The program will address epilepsy-related knowledge and misconceptions, stigma and self-stigma, disclosure and concealment of epilepsy, communication, medication adherence, seizure triggers, stress management, seizure diaries, and individual self-management planning. The control group will receive routine care without additional structured education during the study period. Outcomes related to epilepsy stigma, concealment, and self-management will be assessed using validated measurement tools.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
65 (estimated)
First submitted
25 Sept 2026
Start date
14 Jul 2026
Primary completion date
5 Oct 2026
Lead sponsor
Muş Alparslan University
Diseases
Epilepsy
NCT number
NCT07863310

What you commit to

  • Study type: Interventional
  • Planned participants: 65
  • From 14 Jul 2026 to the primary completion date, 5 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of a severe neurological disorder other than epilepsy
  • Presence of a serious psychiatric disorder
  • Advanced cognitive impairment or any condition preventing effective communication

Other

  • Unable to attend the educational sessions regularly
  • Major change in the treatment protocol during the study
  • Incomplete completion of data collection forms
  • Withdrawal from the study at any stage

Who the study is looking for

  • Age 18 years or older
  • Diagnosed with epilepsy at least 6 months before enrollment
  • Able to communicate and participate in the education program without a cognitive or psychiatric condition that would prevent participation
  • Able to read and understand Turkish
  • Willing to participate in the study
  • Provides written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Malatya Training and Research Hospital
Coordinator of this site? Confirm its status
MalatyaTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.